Equivalent‐quality unflattened photon beam modeling, planning, and delivery

Yunfei Huang, Ryan T. Flynn, Alfredo Rates, R Siochi, John E. BayouthJournal of Applied Clinical Medical Physics 2013 · DOI

TL;DR

This paper demonstrates that an "equivalent quality" unflattened photon beam (eqUF) can be accurately modeled, planned, and delivered using standard treatment planning systems (TPS) and techniques. This finding is crucial for adopting flattening filter-free (FFF) beams, which offer faster treatment times, without compromising dosimetric accuracy in complex IMRT treatments, even for gated deliveries.

What Problem Does This Paper Address?

Flattening filter-free (FFF) photon beams are gaining traction in radiation therapy due to their significantly higher dose rates, which can dramatically reduce treatment times. However, these beams have different characteristics than traditional flattened (WF) beams, including a softer energy spectrum and a more pronounced dose falloff away from the central axis. This necessitates a thorough understanding and validation of their modeling, planning, and delivery accuracy within existing clinical workflows and TPS. Specifically, this paper addresses the challenge of creating an "equivalent quality" FFF beam that matches the beam quality of a conventional 6 MV flattened beam, and then verifying its performance in complex IMRT planning and delivery, particularly for gated treatments where beam interruptions are frequent.

Methods

The researchers developed an "equivalent quality" unflattened (eqUF) photon beam by removing the flattening filter from a 6 MV beam and adjusting the electron energy. This eqUF beam was then modeled in the Pinnacle³ Treatment Planning System (TPS). The modeling process involved using measured beam data (%dd and profiles) to fit the TPS parameters. The accuracy of the eqUF beam model was evaluated using gamma index tests (2%/2 mm) across various regions and depths.

For treatment planning, hypofractionated IMRT plans for liver cancer patients were created using both the WF and eqUF beam models with identical constraints. The equivalence of these plans was assessed through DVH comparisons, analysis of dose hot/cold spots, and a generalized 3D gamma index test.

To evaluate delivery accuracy, particularly for gated treatments, the IMRT plans were delivered to a phantom at high dose rates (1500 MU/min for eqUF vs. 300 MU/min for WF). Dosimetric accuracy was verified using ion chamber measurements at the isocenter and film dosimetry for 2D dose distributions, compared against planned values using gamma index tests. Finally, clinical patient-specific QA data for ten treated eqUF IMRT plans were reviewed using both measurement-based and independent calculation-based methods.

Datasets

The study utilized measured beam data (%dd and cross-axis profiles) collected from a Siemens ONCOR Avant-Garde linear accelerator for both WF and eqUF beams. This data was used to commission and validate the beam models within the Pinnacle³ TPS. Additionally, ten hypofractionated IMRT liver cancer patient treatment plans were used for planning and delivery verification. Respiratory trace data from previously treated liver cancer patients was used for the gated delivery experiments.

Key Insights and Ideas

  • Achieving "Equivalent Quality": By tuning the electron energy, researchers could create an unflattened beam that closely matched the beam quality of a conventional flattened beam, crucial for direct comparison and seamless integration into existing workflows.
  • FFF Beam Modeling Simplicity: The absence of a flattening filter simplifies some aspects of beam modeling, leading to potentially better accuracy in modeling lateral dose falloff and out-of-field regions.
  • High-Dose Rate Gated Delivery is Feasible: The study demonstrates that FFF beams, with their high dose rates, can be accurately delivered in gated IMRT modes, maintaining similar dosimetric precision as slower WF beams.
  • Clinical Equivalence: The core finding is that IMRT plans generated with the eqUF beam are clinically indistinguishable from those generated with the WF beam, both in terms of plan quality and delivery accuracy.

Key Results

  • Beam Modeling Accuracy: The eqUF beam model achieved a high overall passing rate of 99.5% for the 2%/2 mm gamma index test, compared to 96% for the WF beam model, indicating improved modeling accuracy for the eqUF beam, particularly for cross-axis profiles.
  • Treatment Planning Equivalence: DVH comparisons showed no clinically significant differences between WF and eqUF plans. On average, over 98% of voxels passed the 3%/3 mm 3D gamma index test when comparing WF and eqUF plans, confirming their similarity.
  • Gated Delivery Accuracy: Ion chamber measurements for gated deliveries were within 1% of calculated values. Film measurements passed the 3 mm/3% gamma index test with an overall passing rate > 95%. Statistical analysis showed no significant difference (p > 0.3) in gamma index passing rates between WF and eqUF gated deliveries.
  • Clinical QA: Both measurement-based and independent calculation-based QA methods showed strong agreement for eqUF plans, with point dose differences within 2% and relative 2D dose distribution comparisons showing > 95% points within 3% dose difference or 3 mm DTA.

Limitations and Future Work

  • Energy Spectrum Adjustment: The authors suggest that further improvement in %dd data fitting for the eqUF beam model could be achieved by using an energy spectrum specific to the eqUF beam or by adjusting the energy spectrum distribution more aggressively, rather than solely relying on maintaining similarity to the WF beam's spectrum.
  • Clinical Data Expansion: While ten clinical cases were reviewed for QA, the authors suggest that their findings indicate that existing QA programs for WF beams can be adapted for FFF beams, implying that further validation across a wider range of clinical scenarios would be beneficial.
  • Out-of-Field Dose: The paper notes that the improved modeling in the tail section for the eqUF beam is advantageous for IMRT planning where out-of-field dose is a concern, suggesting this as an area for continued investigation.

Summary updated

Abstract

The clinical application of the flattening filter-free photon beam (FFF) has enjoyed greater use due to its advantage of reduced treatment time because of the increased dose rate. Its unique beam characteristics, along with the very high-dose rate, require a thorough knowledge of the capability and accuracy in FFF beam modeling, planning, and delivery. This work verifies the feasibility of modeling an equivalent quality unflattened photon beam (eqUF), and the dosimetric accuracy in eqUF beam planning and delivery. An eqUF beam with a beam quality equivalent to a conventional 6 MV photon beam with the filter in place (WF) was modeled for the Pinnacle3 TPS and the beam model quality was evaluated by gamma index test. Results showed that the eqUF beam modeling was similar to that of the WF beam, as the overall passing rate of the 2%/2 mm gamma index test was 99.5% in the eqUF beam model and 96% in the WF beam model. Hypofractionated IMRT plans were then generated with the same constraints using both WF and eqUF beams, and the similarity was evaluated by DVH comparison and generalized 3D gamma index test. The WF and eqUF plans showed no clinically significant differences in DVH comparison and, on average > 98% voxels passed the 3%/3 mm 3D gamma index test. Dosimetric accuracy in gated phantom delivery was verified by ion chamber and film measurements. All ion chamber measurements at the isocenter were within 1% of calculated values and film measurements passed the 3 mm/3% gamma index test with an overall passing rate > 95% in the high-dose and low-gradient region in both WF and eqUF cases. Treatment plan quality assurance (QA), using either measurement-based or independent calculation-based methods of ten clinically treated eqUF IMRT plans were analyzed. In both methods, the point dose differences were all within 2% difference. In the relative 2D dose distribution comparison, >95% points were within 3% dose difference or 3 mm DTA.
BibTeX
@article{huang2013equivalentquality,
  author = {Yunfei Huang and Ryan T. Flynn and Alfredo Rates and R Siochi and John E. Bayouth},
  title = {{Equivalent‐quality unflattened photon beam modeling, planning, and delivery}},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2013},
  doi = {10.1120/jacmp.v14i4.4211},
}
Figure